Trial intelligence / Profile preview

Phase III pediatric study of Vaxem Hib versus HIBERIX in Chinese infants

2014-005136-33Phase 3

Sponsor
Novartis
Start
Nov 2014
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Haemophilus b conjugate vaccine in Haemophilus influenzae type b disease (Hib), sponsored by Novartis.

02

Drugs

Haemophilus b conjugate vaccine
03

Conditions

Haemophilus influenzae type b disease (Hib)

Beyond the preview

Go deeper on 2014-005136-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005136-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call